Nathalie Adda, Senior VP & Chief Medical Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 25,072 shares at $70.13 ($1.8M) on 2022-01-11, disclosed to the SEC on 2022-01-13.
Open-market sale of $1.8M ENTA by Senior VP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.13 | 12,536 | $879K | 50.0% |
| 2 | $70.13 | 12,536 | $879K | 50.0% |
| Total | $70.13 avg | 25,072 | $1.8M | 100% |
| Filing → |
| ENTA | SELL | 2021-12-03 | $1.9M | — | Filing → |
| ENTA | SELL | 2021-11-02 | $1.6M | — | Filing → |
| ENTA | SELL | 2021-10-13 | $2.5M | — | Filing → |